Business context and reporting period
Omega Healthcare Investors, Inc. filed this Form 8-K on October 5, 2026, under Item 7.01 (Regulation FD Disclosure). The company said it issued a press release announcing a portfolio transition transaction. The press release is identified as Exhibit 99.1, but its text is not included in the supplied filing content.
Financial metrics
This 8-K text provides no transaction values or financial results. Revenue, profit, cash flow, margins, debt, liquidity, and other key metrics are not stated.
Changes, outlook, and risks
The filing identifies a portfolio transition but does not describe its terms, timing, financial effects, outlook, risks, or contingencies. No comparison with a prior period is provided.
Important facts to verify
- Review Exhibit 99.1 for the transaction’s parties, portfolio assets, terms, timing, and expected financial impact.
- Verify whether the transition changes Omega’s tenant, operator, or property exposure, and whether any material contingencies apply.